Francesco Schettini

20PUBLICATIONS
100CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 07, 2026
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.

|Nov 24, 2025
Virtual Biomarkers and Simplified Metrics in the Modeling of Breast Cancer Neoadjuvant Therapy: A Proof-of-Concept Case Study Based on Diagnostic Imaging.

Graziella Marino, Maria Valeria De Bonis, Marisabel Mecca

|Dec 14, 2024
Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses.

Francesco Schettini, Estela Pineda, Andrea Rocca

|Nov 09, 2024
Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes.

Isaac Cebrecos, Ines Torras, Helena Castillo

|Aug 23, 2024
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.

Francesco Schettini, Marianna Sirico, Marco Loddo

|May 16, 2024
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

Francesco Schettini, Eva Blondeaux, Chiara Molinelli

Pageof 4

Frequent Collaborators

8 joint publications

Aleix Prat

4 joint publications

Lucia Del Mastro

3 joint publications

Daniele Generali

3 joint publications

Matteo Lambertini